GROWing Up With Rare GENEtic Syndromes

GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age

Sponsors

Lead Sponsor: dr. Laura C. G. de Graaff-Herder

Source Erasmus Medical Center
Brief Summary

Introduction Rare complex syndromes Patients with complex genetic syndromes, by definition, have combined medical problems affecting multiple organ systems, and intellectual disability is often part of the syndrome. During childhood, patients with rare genetic syndromes receive multidisciplinary and specialized medical care; they usually receive medical care from 3-4 medical specialists. Increased life expectancy Although many genetic syndromes used to cause premature death, improvement of medical care has improved life expectancy. More and more patients are now reaching adult age, and the complexity of the syndrome persists into adulthood. However, until recently, multidisciplinary care was not available for adults with rare genetic syndromes. Ideally, active and well-coordinated health management is provided to prevent, detect, and treat comorbidities that are part of the syndrome. However, after transition from pediatric to adult medical care, patients and their parents often report fragmented poor quality care instead of adequate and integrated health management. Therefore, pediatricians express the urgent need for adequate, multidisciplinary adult follow up of their pediatric patients with rare genetic syndromes. Medical guidelines for adults not exist and the literature on health problems in these adults is scarce. Although there is a clear explanation for the absence of adult guidelines (i.e. the fact that in the past patients with rare genetic syndromes often died before reaching adult age), there is an urgent need for an overview of medical issues at adult age, for 'best practice' and, if possible, for medical guidelines. The aim of this study is to get an overview of medical needs of adults with rare genetic syndromes, including: 1. comorbidities 2. medical and their impact on quality of life 3. medication use 4. the need for adaption of medication dose according to each syndrome Methods and Results This is a retrospective file study. Analysis will be performed using SPSS version 23 and R version 3.6.0.

Overall Status Recruiting
Start Date October 1, 2018
Completion Date January 1, 2030
Primary Completion Date January 1, 2030
Study Type Observational
Primary Outcome
Measure Time Frame
Presence of physical health problems 1 year
Laboratory values 1 year
Physical and psychological complaints 1 year
Medication use 1 year
Enrollment 600
Condition
Intervention

Intervention Type: Diagnostic Test

Intervention Name: Retrospective file studies

Description: No intevention, retrospective file study: medical history, laboratory values, additional tests, physical and psychological complaints.

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria: - Patients with rare syndromes or rare congenital diseases visiting the multidisciplinary outpatient clinic for patients with rare diseases at the department of endocrinology, internal medicine, Erasmus Medical Center. Exclusion Criteria: - None

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

Location
Facility: Status: Contact: Investigator: Erasmus Medical Center Laura CG de Graaff, MD, PhD +31618843010 [email protected] Sabine E Hannema Sub-Investigator
Location Countries

Netherlands

Verification Date

July 2020

Responsible Party

Type: Sponsor-Investigator

Investigator Affiliation: Erasmus Medical Center

Investigator Full Name: dr. Laura C. G. de Graaff-Herder

Investigator Title: Principal investigator

Has Expanded Access No
Condition Browse
Acronym GROW UR GENES
Patient Data Undecided
Study Design Info

Observational Model: Cohort

Time Perspective: Retrospective

Source: ClinicalTrials.gov